Trial Profile
Safety and efficacy of emtricitabine/rilpivirine/tenofovir disoproxil fumarate a switch option in real-life clinical practices
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 New trial record